Resource library

On 4 November 2022, the Commission released the first national Stillbirth Clinical Care Standard to reduce rates of stillbirth and remove the culture of silence.

The standard provides a framework for healthcare practitioners to identify stillbirth risks, communicate effectively with women about reducing risk, discuss clinical investigations after stillbirth, and provide support after perinatal loss.

On 1 September 2022, the Commission released the first national Low Back Pain Clinical Care Standard to improve early management of patients with this common condition, which is a leading cause of disability worldwide.

The standard advocates a shift towards active approaches to support people with low back pain and reduce their chance of ongoing problems.

The Commission invites prospective authors to submit an abstract for WHO World Patient Safety Day 2022. Submit your abstract by emailing it as an attachment to wpsdabstracts@safetyandquality.gov.au.

On 30 June 2022, the Commission released the new Sepsis Clinical Care Standard. The new standard is a ‘game changer’ that will ensure healthcare workers recognise sepsis as a medical emergency.

The Australian Commission on Safety and Quality in Health Care is conducting consultations on the minimum core elements of the national SSA. The aim of the single national SSA is to ensure a single process for local site risk assessment and authorisation for health-related human research.

The Clinical Trials Project Reference Group endorsed in principle the national SSA minimum core elements with agreed amendments for implementation via the National One Stop Shop subject to further feedback through the second phase of national consultations.

On 27 April 2022, the Commission released the new national Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard.

This template letter can be used by healthcare services to communicate with a patient’s general practitioner on discharge following hospitalisation for sepsis. It contains information about post-sepsis syndrome and sepsis recovery.

Isolate Referral Forms must not be forwarded to the Commission. A completed Isolate Referral Form must be sent with a suspected CAR isolate from an originating laboratory to the appropriate confirming laboratory to enable submission to CARAlert via the web portal.